# Phase 3A GO / NO-GO

## Current conclusion

GO FOR SYNTHETIC SHADOW TESTING ONLY.

NO-GO for clinical production, real patient data, patient-facing messaging, medication changes, prescription workflow, EMR/HIS write-back or production pathway.

## Required conditions to remain GO

- Risky feature flags remain false.
- Synthetic case validation passes.
- Focused functional/safety/red-team tests pass.
- Approval bypass count is 0.
- PII export count is 0.
- Clinical release flag bypass count is 0.
- Patient-facing output without approval count is 0.

## Verification 2026-06-18

- Focused Phase 3A tests: 20 passed.
- Full pytest: 313 passed, 1 warning.
- Ruff: PASS.
- Compileall: PASS.
- EBM audit: PASS.

## Final Phase 3A decision

GO for synthetic read-only shadow pilot.

NO-GO for production, real patient data, patient-facing output, medication workflow, prescription workflow, EMR/HIS write-back, auto-apply or clinical release.
